141 related articles for article (PubMed ID: 16683887)
1. Evaluation of Her-2/neu gene status in osteosarcoma by fluorescence in situ hybridization and multiplex and monoplex polymerase chain reactions.
Willmore-Payne C; Holden JA; Zhou H; Gupta D; Hirschowitz S; Wittwer CT; Layfield LJ
Arch Pathol Lab Med; 2006 May; 130(5):691-8. PubMed ID: 16683887
[TBL] [Abstract][Full Text] [Related]
2. Amplification of the HER-2/neu oncogene is uncommon in pediatric osteosarcomas.
Maitra A; Wanzer D; Weinberg AG; Ashfaq R
Cancer; 2001 Aug; 92(3):677-83. PubMed ID: 11505415
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of HER2/neu expression by real-time PCR and fluorescent in situ hybridization analysis in low-grade osteosarcoma.
Lee WI; Bacchni P; Bertoni F; Maeng YH; Park YK
Oncol Rep; 2004 Jul; 12(1):125-8. PubMed ID: 15201972
[TBL] [Abstract][Full Text] [Related]
4. Her-2/neu expression in osteosarcoma increases risk of lung metastasis and can be associated with gene amplification.
Zhou H; Randall RL; Brothman AR; Maxwell T; Coffin CM; Goldsby RE
J Pediatr Hematol Oncol; 2003 Jan; 25(1):27-32. PubMed ID: 12544770
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas.
Anninga JK; van de Vijver MJ; Cleton-Jansen AM; Kristel PM; Taminiau AH; Nooij M; Egeler RM; Hogendoorn PC
Eur J Cancer; 2004 May; 40(7):963-70. PubMed ID: 15093570
[TBL] [Abstract][Full Text] [Related]
6. Copy number analysis of c-erb-B2 (HER-2/neu) and topoisomerase IIalpha genes in breast carcinoma by quantitative real-time polymerase chain reaction using hybridization probes and fluorescence in situ hybridization.
Murthy SK; Magliocco AM; Demetrick DJ
Arch Pathol Lab Med; 2005 Jan; 129(1):39-46. PubMed ID: 15628907
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the predictive value of Her-2/neu gene expression on osteosarcoma therapy in laser-microdissected paraffin-embedded tissue.
Fellenberg J; Krauthoff A; Pollandt K; Delling G; Parsch D
Lab Invest; 2004 Jan; 84(1):113-21. PubMed ID: 14631380
[TBL] [Abstract][Full Text] [Related]
8. Absence of HER2/neu gene expression in osteosarcoma and skeletal Ewing's sarcoma.
Thomas DG; Giordano TJ; Sanders D; Biermann JS; Baker L
Clin Cancer Res; 2002 Mar; 8(3):788-93. PubMed ID: 11895910
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma.
Baumhoer D; Smida J; Specht K; Bink K; Quintanilla-Martinez L; Rosemann M; Siggelkow H; Nathrath WB; Atkinson MJ; Bielack S; Jundt G; Nathrath M
Hum Pathol; 2011 Jun; 42(6):859-66. PubMed ID: 21292304
[TBL] [Abstract][Full Text] [Related]
10. Integrated assessment of potential value of erbB-2 amplification or expression status as novel therapy target in Chinese children and adolescents with osteosarcoma.
Shang J; Bi ZG; Ji HF; Wang WB
Chin Med J (Engl); 2009 Jul; 122(13):1521-4. PubMed ID: 19719941
[TBL] [Abstract][Full Text] [Related]
11. HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization.
Ross JS; Sheehan C; Hayner-Buchan AM; Ambros RA; Kallakury BV; Kaufman R; Fisher HA; Muraca PJ
Hum Pathol; 1997 Jul; 28(7):827-33. PubMed ID: 9224752
[TBL] [Abstract][Full Text] [Related]
12. HER-2/neu and p53 in osteosarcoma: an immunohistochemical and fluorescence in situ hybridization analysis.
Tsai JY; Aviv H; Benevenia J; Chang VT; Patterson F; Aisner S; Hameed M
Cancer Invest; 2004; 22(1):16-24. PubMed ID: 15069760
[TBL] [Abstract][Full Text] [Related]
13. Her-2/neu Oncogene Amplification by Fluorescence In Situ Hybridization and Protein Overexpression on Immunohistochemistry in Breast Cancer.
Lateef F; Jamal S; Nasir S
J Coll Physicians Surg Pak; 2018 Aug; 28(8):581-585. PubMed ID: 30060783
[TBL] [Abstract][Full Text] [Related]
14. HER-2 status in breast cancer: correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system.
Ciampa A; Xu B; Ayata G; Baiyee D; Wallace J; Wertheimer M; Edmiston K; Khan A
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):132-7. PubMed ID: 16785779
[TBL] [Abstract][Full Text] [Related]
15. Detection of HER-2/neu gene amplification in breast cancer using a novel polymerase chain reaction/ligase detection reaction technique.
Nathanson DR; Nash GM; Chen B; Gerald W; Paty PB
J Am Coll Surg; 2003 Sep; 197(3):419-25. PubMed ID: 12946797
[TBL] [Abstract][Full Text] [Related]
16. HER 2/neu expression and gene amplification in colon cancer.
Nathanson DR; Culliford AT; Shia J; Chen B; D'Alessio M; Zeng ZS; Nash GM; Gerald W; Barany F; Paty PB
Int J Cancer; 2003 Jul; 105(6):796-802. PubMed ID: 12767065
[TBL] [Abstract][Full Text] [Related]
17. HER-2/neu overexpression and amplification in uterine serous papillary carcinoma: comparative analysis of immunohistochemistry, real-time reverse transcription-polymerase chain reaction, and fluorescence in situ hybridization.
Odicino FE; Bignotti E; Rossi E; Pasinetti B; Tassi RA; Donzelli C; Falchetti M; Fontana P; Grigolato PG; Pecorelli S
Int J Gynecol Cancer; 2008; 18(1):14-21. PubMed ID: 17451461
[TBL] [Abstract][Full Text] [Related]
18. Determination of HER2/neu status: a pilot study comparing HER2/neu dual in situ hybridization DNA probe cocktail assay performed on cell blocks to immunohistochemisty and fluorescence in situ hybridization performed on histologic specimens.
Hartman AK; Gorman BK; Chakraborty S; Mody DR; Schwartz MR
Arch Pathol Lab Med; 2014 Apr; 138(4):553-8. PubMed ID: 24678687
[TBL] [Abstract][Full Text] [Related]
19. An alternative and reliable real-time quantitative PCR method to determine HER2/neu amplification in breast cancer.
Egervari K; Toth J; Nemes Z; Szollosi Z
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):247-54. PubMed ID: 19098680
[TBL] [Abstract][Full Text] [Related]
20. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone.
Dujardin F; Binh MB; Bouvier C; Gomez-Brouchet A; Larousserie F; Muret Ad; Louis-Brennetot C; Aurias A; Coindre JM; Guillou L; Pedeutour F; Duval H; Collin C; de Pinieux G
Mod Pathol; 2011 May; 24(5):624-37. PubMed ID: 21336260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
